- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01952210
Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer Patient
April 22, 2014 updated by: National Taiwan University Hospital
The Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer Patient Receiving Neoadjuvant Chemoradiation.
In this randomized pilot study, a nutritional consultation combining exercise program is planned for 25 locally advanced esophageal cancer patients undergoing neoadjuvant chemoradiation.
The purpose of this study is to determine the effects of nutritional and exercise intervention in locally advanced esophageal cancer patients undergoing neoadjuvant chemoradiation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients with esophageal cancer are often malnourished at presentation due to the primary symptom of dysphagia.
Treatments for esophageal cancer are commonly multimodal, incorporating polychemotherapy, radiotherapy and surgery.
These treatments frequently cause or exacerbate poor nutritional status.
Recent literature has proved that malnutrition is associated with longer hospital stays, reduced responses to and increased complications from therapies, increased costs, worse quality of life and lower survival rate.
The aim of this study was to investigate the effectiveness of an intensive nutritional consultation and exercise program on nutritional status and outcomes in patients undergoing chemoradiation for esophageal cancer.
Study Type
Interventional
Enrollment (Actual)
56
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of locally advanced esophageal cancer, neoadjuvant chemoradiation is indicated
- Informed consent signed
Exclusion Criteria:
- stage IV, underwent palliative chemotherapy or radiotherapy patient
- clinically significant cardiac or pulmonary disease
- Unable to walk or exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: nutrition consultation and exercise program
individual nutritional consultation and exercise
|
The protocol involved 20-30 minutes of individual-based nutrition consultation every week during the 8-week chemoradiation therapy.
The exercise program consisted of upper extremity muscle training and walking exercise at 45%-65% of maximal heart rate reserve, 3 times per week, 20-30 minutes per session.
Other Names:
|
|
Active Comparator: usual care
pre-CCRT education included self-care during CCRT and body weight maintenance
|
pre-CCRT education included self-care during CCRT and body weight maintenance
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
General nutritional status
Time Frame: 10 weeks
|
Measure tools included patient-generated-subjective global assessment score, hand-grip strength, body weight, body composition analysis, and 6-mim walk test were used to define the general nutritional status of esophageal cancer patient.
The study measures were chosen on the basis that they had been utilized in previous cancer trials examining the effects of various interventions on weight loss, endurance and strength, and simple enough to be administered in the clinical setting.
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment tolerance
Time Frame: 10 weeks
|
To evaluate the treatment tolerance, the following data were assessed: number of treatment breaks or delay for toxicity, grading of acute chemoradiation-related toxicity, number of unplanned hospitalization for adverse effects.
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Cheryl Chia-Hui Chen, Department of Nursing, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
September 24, 2013
First Submitted That Met QC Criteria
September 24, 2013
First Posted (Estimate)
September 27, 2013
Study Record Updates
Last Update Posted (Estimate)
April 23, 2014
Last Update Submitted That Met QC Criteria
April 22, 2014
Last Verified
April 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201205017RIC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophageal Cancer
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityWithdrawnStage IIB Esophageal Cancer AJCC v7 | Stage III Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7
-
National Cancer Institute (NCI)NRG OncologyCompletedEsophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IB Esophageal Cancer AJCC v7United States
-
Essen BiotechRecruitingStomach Cancer | Esophageal Cancer | Stomach Cancer, Adenocarcinoma | Stomach Cancer Recurrent | Esophageal Cancer Metastatic to Bone | Esophageal Cancer Metastatic to Lung | Esophageal Cancer Metastatic to LiverChina
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedEsophageal Cancer | Gastrooesophageal Cancer | Oesophageal Cancer | GastroEsophageal Cancer | Esophageal Cancers NOS | Oesophageal Cancer Metastatic | Esophageal Cancer Metastatic | Oesophageal Cancer NosGermany
-
University of Wisconsin, MadisonCompletedResectable Esophageal Cancer | GastroEsophageal CancerUnited States
-
Tianjin Medical University Cancer Institute and...Sun Yat-sen University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsNot yet recruitingStage III Esophageal Cancer | Stage II Esophageal Cancer
-
Tianjin Medical University Cancer Institute and...UnknownStage III Esophageal Cancer | Stage II Esophageal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Tianjin Medical University Cancer Institute and Hospital; Sichuan Cancer Hospital...UnknownEsophageal Neoplasm | Esophageal Cancer TNM Staging Primary Tumor (T) T3 | Esophageal Cancer TNM Staging Primary Tumor (T) T2 | Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0 | Esophageal Cancer TNM Staging Distal Metastasis (M) M0China
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC UtrechtCompletedEsophageal Cancer, Stage II | Esophageal Cancer Stage IIINetherlands
-
Tianjin Medical University Cancer Institute and...The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsUnknownEsophageal Cancer Stage III | Esophageal Cancer Stage IIBChina
Clinical Trials on nutritional consultation and exercise program
-
University of ArkansasCompletedCirrhosis | Sarcopenia | Portal Hypertension | Liver Transplant | End-stage Liver Disease (ESLD) | Poor Physical FitnessUnited States
-
Dublin City UniversityRoyal College of Surgeons, Ireland; Mater Misericordiae University HospitalActive, not recruitingOvarian Cancer | Colon Cancer | Appendix Cancer | Rectum Cancer | Peritoneal MalignancyIreland
-
US Department of Veterans AffairsCompletedPain | Obesity | Osteoarthritis | Chronic DiseasesUnited States
-
Complejo Hospitalario Universitario de AlbaceteRecruiting
-
University of ChicagoCompletedObesity | Type 2 DiabetesUnited States
-
University of MiamiRecruiting
-
Cairo UniversityCompleted
-
Ruijin HospitalNot yet recruitingCOVID-19 | Hemodiafiltration
-
Massachusetts General HospitalRecruitingMuscle Mass and StrengthUnited States
-
Jewish General HospitalUniversity of British Columbia; Centre hospitalier de l'Université de Montréal... and other collaboratorsUnknownExercise | Rehabilitation | Transcatheter Aortic Valve Replacement | Frail Elderly | Postoperative Care | Dietary SupplementsCanada